Cargando…

Correction to: A multicenter, double-blind, randomized trial on the bleeding profle of a drospirenone-only pill 4 mg over nine cycles in comparison with desogestrel 0.075 mg

Detalles Bibliográficos
Autores principales:	Palacios, Santiago, Colli, Enrico, Regidor, Pedro-Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246239/ https://www.ncbi.nlm.nih.gov/pubmed/32328709 http://dx.doi.org/10.1007/s00404-020-05544-z

Ejemplares similares

Bleeding profile of women using a drospirenone-only pill 4 mg over nine cycles in comparison with desogestrel 0.075 mg
por: Palacios, S., et al.
Publicado: (2020)

A multicenter, double-blind, randomized trial on the bleeding profile of a drospirenone-only pill 4 mg over nine cycles in comparison with desogestrel 0.075 mg
por: Palacios, Santiago, et al.
Publicado: (2019)

Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime
por: Palacios, Santiago, et al.
Publicado: (2020)

Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone‐only pill
por: Palacios, Santiago, et al.
Publicado: (2019)

Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone
por: Römer, Thomas, et al.
Publicado: (2021)

Case of rupture ectopic pregnancy with emergency contraception levonorgestrel 0.075 mg in a lactating woman
por: Masud, Nazish, et al.
Publicado: (2021)

A single-arm study to evaluate the transfer of drospirenone to breast milk after reaching steady state, following oral administration of 4 mg drospirenone in healthy lactating female volunteers
por: Melka, Dace, et al.
Publicado: (2020)

Correction: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone
por: Römer, Thomas, et al.
Publicado: (2021)

Evaluation of the food effect on a drospirenone only contraceptive containing 4 mg administered with and without high-fat breakfast in a randomised trial
por: Regidor, P.-A., et al.
Publicado: (2022)

Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen
por: Regidor, Pedro-Antonio, et al.
Publicado: (2023)

A 1-year prospective, open-label, single-arm, multicenter, phase 3 trial of the contraceptive efficacy and safety of the oral progestin-only pill drospirenone 4 mg using a 24/4-day regimen()()
por: Kimble, Thomas, et al.
Publicado: (2020)

A Comparative Efficacy of Low-Dose Combined Oral Contraceptives Containing Desogestrel and Drospirenone in Premenstrual Symptoms
por: Wichianpitaya, Jirath, et al.
Publicado: (2013)

Hormone withdrawal-associated symptoms with ethinylestradiol 20 μg/drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 μg/desogestrel 150 μg (21/7 regimen)
por: Bitzer, Johannes, et al.
Publicado: (2015)

Bleeding Pattern and Management of Unexpected Bleeding/Spotting with an Extended Regimen of a Combination of Ethinylestradiol 20 mcg and Drospirenone 3 mg
por: Bonassi Machado, Rogerio, et al.
Publicado: (2020)

Efficacy and safety of drospirenone 2 mg/17β-estradiol 1 mg hormone therapy in Korean postmenopausal women
por: Park, Bo Ra, et al.
Publicado: (2017)

An Oral Contraceptive Containing Estetrol 15 MG and Drospirenone 3 MG Has Limited Effects on Endocrine and Metabolic Parameters
por: Klipping, Christine, et al.
Publicado: (2021)

Hydrostatic pressure effects on the static magnetism in Eu(Fe(0.925)Co(0.075))(2)As(2)
por: Jin, W. T., et al.
Publicado: (2017)

Heterogeneously Catalyzed Pechmann Condensation Employing the Tailored Zn(0.925)Ti(0.075)O NPs: Synthesis of Coumarin
por: Jadhav, Nirajkumar H., et al.
Publicado: (2019)

The Effect of Rare Earths Additions on the Microstructure and the Corrosion Behavior of Sn-0.7Cu-0.075Al Solder Alloy
por: Yang, Wenchao, et al.
Publicado: (2019)

Effects of hormone therapy containing 2 mg drospirenone and 1 mg 17β-estradiol on postmenopausal exacerbation of Meniere's disease: Preliminary study
por: Grillo, Caterina Maria, et al.
Publicado: (2021)

Analgesia epidural durante el trabajo de parto con ropivacaína al 0.1%, 0.075% y 0.05%
por: Colmenares Sánchez, María del Pilar
Publicado: (2002)

ED(90) of epidural esketamine with 0.075% ropivacaine for labor analgesia in nulliparous parturients: a prospective, randomized and dose-finding study
por: Lou, Siwen, et al.
Publicado: (2023)

A randomized double-masked study to compare the ocular safety, tolerability, and efficacy of bromfenac 0.075% compared with vehicle in cataract surgery subjects
por: Hosseini, Kamran, et al.
Publicado: (2016)

Desogestrel: Arterial thrombosis: case report
Publicado: (2021)

The Uncharted Link Between Desogestrel and Hypercalcemia
por: Utpat, Nishka, et al.
Publicado: (2023)

Twice-Daily vs. Once-Daily Dosing with 0.075% Bromfenac in DuraSite: Outcomes from a 14-Day Phase 2 Study
por: Trattler, William, et al.
Publicado: (2017)

In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits
por: Sheppard, John D., et al.
Publicado: (2018)

The Efficacy of the Yasmin[Ethinylestradiol-Drospirenone (0.03/3 mg)] Treatment for Postoperative Abortion: A Protocol of Meta-Analysis
por: Tian, Tian, et al.
Publicado: (2022)

Antiandrogenic and antimineralocorticoid health benefits of COC containing newer progestogens: dienogest and drospirenone
por: Regidor, Pedro-Antonio, et al.
Publicado: (2017)

Drospirenone and mood
por: Zuschmann, Andrew
Publicado: (2022)

Correction to: Association of cord blood asprosin concentration with atherogenic lipid profle and anthropometric indices
por: Hussein, Hanan Khudhair, et al.
Publicado: (2022)

Preparation of Eu(0.075)Tb(0.925)-Metal Organic Framework as a Fluorescent Probe and Application in the Detection of Fe(3+) and Cr(2)O(7)(2−)
por: Yin, Jie, et al.
Publicado: (2021)

‘Walking epidural’: comparison of the analgesic efficacy of levobupivacaine 0.0625% + fentanyl 2mcg/mL versus ropivacaine 0.075% + fentanyl 2mcg/mL
por: Mingote, Álvaro, et al.
Publicado: (2023)

Norethisterone Reduces Vaginal Bleeding Caused by Progesterone-Only Birth Control Pills
por: Vilk Ayalon, Naama, et al.
Publicado: (2022)

Safety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorder
por: Breech, Lesley L, et al.
Publicado: (2010)

Contraceptive efficacy and tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study
por: Klipping, Christine, et al.
Publicado: (2012)

Quality of Life in Japanese Patients with Dysmenorrhea Treated with Ethinylestradiol 20 μg/Drospirenone 3 mg in a Real-World Setting: An Observational Study
por: Momoeda, Mikio, et al.
Publicado: (2020)

The effectiveness of desogestrel for endometrial protection in women with abnormal uterine bleeding-ovulatory dysfunction: a non-inferiority randomized controlled trial
por: Soontrapa, Nisarath, et al.
Publicado: (2022)

EHMTI-0075. Is insomnia associated with migraineurs attributable to anxiety and depression?
por: Chu, M, et al.
Publicado: (2014)

Long-term tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study
por: Klipping, Christine, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2ubn2ocbho75ee1rfacbajiueo